RVTY250117P110000
- 0.00
- 0.000.00%
Revvity Newsroom
Express News | Revvity Inc : Jefferies Cuts Target Price to $120 From $125
UBS Says 'Underweight the Names With High China Exposure'
China Neurogenomics Market Research 2024-2031, Profiles of Illumina, Thermo Fisher Scientific, F. Hoffmann-La Roche, MGI Tech, Agilent, Revvity, Qiagen, Pacific Biosciences, Danaher, Oxford Nanopore - ResearchAndMarkets.com
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
Does Revvity (NYSE:RVTY) Have A Healthy Balance Sheet?
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year
Dow Breaks Downward Spiral, with FOMC Rate Cut on Deck | Live Stock
Citi Maintains Revvity(RVTY.US) With Buy Rating, Maintains Target Price $145
Revvity's Strategic Market Position and Anticipated Growth Drive Buy Rating
Tuesday, Tech Pulls Back, While Traders Await FOMC Rate | Wall Street Today
Tuesday Tech Pull Back After Nasdaq and Bitcoin Record | Live Stock
Revvity to Present at J.P. Morgan Healthcare Conference
Another Week, Another Index Record | Lkive Stock
Weekly Buzz: Tech stocks hit high scores on ominous day
Revvity Analyst Ratings
Market Mixed on Friday the 13th | Livestock
BofA Securities Upgrades Revvity(RVTY.US) to Buy Rating, Announces Target Price $138
BofA Securities Upgrades Revvity to Buy From Neutral
Thursday Ends in Index Declines | Wall Street Today